Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Verena Korber, who has been awarded a Career Development Fellowship from Cancer Research UK.

Poster image showing a headshot of Verena next to the words "CRUK Career Development Fellowship"

Cancer Research UK’s Career Development Fellowship provides support for new group leaders establishing their independent research group.  In this CRUK-funded project, Verena Korber and her team will develop advanced mathematical models of human blood production in health and leukaemia.

Blood is a mixture of cells that support our body with nutrients and protect us from infections. While some blood cells persist for years, most are short-lived and must be continually replaced. This renewal is achieved by an intricate hierarchy: long-lived stem cells in our bone marrow produce so-called progenitor cells that, ultimately, give rise to diverse mature blood cells.

In leukaemia - a cancer of the blood - this hierarchy becomes perturbed. Progenitors lose their normal function and accumulate in bone marrow and blood. Mature blood cells are displaced and blood function can no longer be maintained. Although DNA mutations are known to drive this process, key questions remain about when these mutations first arise and how they alter the dynamics of stem and progenitor cell activity.

To address these questions, the team will use naturally occurring DNA changes in blood cells as markers. By tracking these changes in blood and bone marrow samples of patients with leukaemia, they aim to reconstruct when the disease began, how quickly it evolved, and how normal blood production changed over time. These insights could improve early diagnosis and risk stratification, and help guide therapeutic intervention.

Speaking about the award, Dr Verena Korber said:

This fellowship is a unique opportunity for me and my team, and I am incredibly grateful to my mentors for their support throughout my journey. I look forward to building a collaborative, multidisciplinary research group dedicated to uncovering the timescales of cancer development in humans.

Recent stories

Immune sensor can detect viral infection by monitoring cell’s own RNA

A recent study by the Rehwinkel Group and collaborators reveals a new way the immune sensor MDA5 can recognise viral infection – not only through viral RNA, but by monitoring changes to the cell’s own RNA processing.

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Expanding OxCITE: New funding to accelerate immunotherapy research

New funding from Cancer Research Horizons will help researchers to better understand why some patients respond well to immunotherapy while others do not.

Professor Marella de Bruijn receives MRC Programme Award

Congratulations to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

Professor Bethan Psaila wins ISEH Janet Rowley Award

Congratulations to Professor Psaila, who has received the 2026 Janet Rowley Award from the International Society for Experimental Hematology, in recognition of her outstanding contributions in the field of experimental haematology.